Search results
Results from the WOW.Com Content Network
The team used health data from more than 350,000 people who had been recruited for the UK Biobank study between 2006 and 2010 and participated in follow-up assessments three times over the next ...
A history of two or more prior head injuries was associated with over two times increased risk of dementia. Be physically active Studies show that being physically active can help lower your risk ...
Dementia impacts not only individuals with dementia, but also their carers and the wider society. Among people aged 60 years and over, dementia is ranked the 9th most burdensome condition according to the 2010 Global Burden of Disease (GBD) estimates. The global costs of dementia was around US$818 billion in 2015, a 35.4% increase from US$604 ...
[7] [10] [83] Mirtazapine and SSRIs can be used to treat depression, depending on how well they are tolerated, and guided by general advice for the use of antidepressants in dementia. [65] Antidepressants with anticholinergic properties may worsen hallucinations and delusions. [86] People with Capgras syndrome may not tolerate AChEIs. [64]
A 2012 review focused on antidepressants and sleep found that mirtazapine reduced the time it took to fall asleep and improved the quality of sleep in many people with sleep disorders caused by depression, but that it could also disturb sleep in many people, especially at higher doses, causing restless leg syndrome in 8 to 28% of people and in ...
Dementia and brain disorders are getting a lot of attention these days. And for good reason. About 1 in 10 Americans over 65 have dementia. And it’s estimated that the number of people 65 and ...
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants. [1] They act by antagonizing the α 2 -adrenergic receptor and certain serotonin receptors such as 5-HT 2A and 5-HT 2C , [ 1 ] but also 5-HT 3 , [ 1 ] 5-HT 6 , and/or 5-HT 7 in some cases.
Not only that, they had a 52 percent lower risk of vascular dementia, and a 39 percent lower risk of Alzheimer’s dementia. People who took SGLT-2 inhibitors for longer periods of time seemed to ...